LEI 6437 DE 1977 PDF

29 jul. órgão emissor: ANVISA – Agência Nacional de Vigilância Sanitária na forma da Lei n° , de 20 de agosto de , sujeitando o infrator. Relevant documents: (1) Brazilian Official Journal (Diário Oficial da Uniăo) Nº page 42, (2)Law , 20 August (Lei nº , de 20 de. Saúde Pública, Rio de Janeiro, 23(6), jun, . ; National Health Surveillance Secretariat (SNVS) Important health control legislation enacted, still in force (Acts 5,/73, 6,/76, and 6,/77 .. Lei no . Cria a Agência Nacional de Vi- gilância Sanitária, define o Sistema Nacional de Vi-.

Author: Arazshura Goltimi
Country: Russian Federation
Language: English (Spanish)
Genre: Video
Published (Last): 18 December 2005
Pages: 324
PDF File Size: 18.88 Mb
ePub File Size: 13.89 Mb
ISBN: 191-1-57259-173-6
Downloads: 7368
Price: Free* [*Free Regsitration Required]
Uploader: Nejas

Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives.

lei no 6437 de 20 de agosto de 1977 pdf to excel

Harassment of medical professionals by pharmaceutical companies may also compromise the professional training of medical students.

The pharmaceutical industry uses leu to promote its products. Although it would be reasonable to consider that educational interventions within this field are welcome, it seems very unlikely that separate actions will be enough to prepare students to deal critically and autonomously with modern marketing. Other types of conflict of interest were not significantly associated with the authors’ conclusions.

.: Portal da SBO – Sociedade Brasileira de Oftalmologia :.

The results showed that physicians who were trained under the guidance of this policy had a lower tendency to regard information from pharmaceutical representatives as beneficial for orienting their practice than did those who had not been trained under this guidance. Review of developments in corneal transplantation in the regions of Brazil – Evaluation of corneal transplants in Brazil. This report aims at identifying and sharing the best practices, recognizing possible flaws in the process, and tracking ee and global trends in keratoplasty.

Promotion and advertising of medications and self-regulation Although advertising of medications and other health-related products has specific features, in a general manner it has the same objective as any other advertising: This lack of uniformity in the availability of national data can lead to mistaken analyzes and adoption of incorrect decisions in public health, increasing the social, cultural and economic heterogeneity among the regions of Brazil, and causing losses and delays in the cornea transplant system in Brazil.

This author defined five critical points relating to the application of codes that need to be publicly released: Among many things to be done, some immediately viable and others less so, the most significant and viable of these is to work towards training physicians who are more aware of the influence of pharmaceutical corporations as they 19977 about their lives and activities.


How to cite this article. However, it seems that most physicians believe that their professional integrity is immune to advertising actions and that the actions of pharmaceutical company representatives and the gifts, sponsorship or funding from the industry do not influence their practice, 19977 at least the quality of their practice.

Drug promotion and advertising in teaching environments: elements for debate

The importance that the pharmaceutical industry bestows on advertising its products is expressed in the distribution of its expenditure. Gifts to physicians from the pharmaceutical industry. The responsibilities of SNT lfi financing management, donation stimulation, recruitment logistics, accreditation of surgical teams and transplantation centers, and drafting of ordinances to regulate the process. However, such stratagems or artifices, which possibly are recognized as advertising techniques, do not comply with the sanitary legislation in its most important aspect: In Brazil, in recognition of the potential risks involved in sponsorship and advertising, the Federal Medical Council Conselho Federal de MedicinaCFM has issued resolutions prohibiting linkage between medical prescriptions and receipt of material advantages offered by economic agents with interests in the production or commercialization of pharmaceutical products or equipment for medical use.

What was the CFM seeking through these prohibitions? The scientific studies that we will present below show that the scientific references presented in publicity material are not always trustworthy.

Prohibition llei the presence of pharmaceutical representatives inside healthcare units destined for teaching is a measure a drastic one, without doubt that was adopted by McMaster University in Barros and Joany evaluated advertisements for medications in three large-circulation Brazilian medical journals and noted that there was a great shortage of information.

Gifts to physicians in the consumer marketing era. It should be noted that this review did not have any financial assistance, and that the authors declare no conflicts of interest.

In, corneas of 69, donors were collected, and 82, keratoplasty were performed in the country. In other words, “to stop advertising professionals’ actions from affecting the basis for professionals and the competition to coexist, as well as ensuring a degree of protection to society” Rego,p. The need to control uncertainties and 4637 that ds students have, and their lack of knowledge of the strategies and practices of the pharmaceutical industry for promoting their products, leave them extremely vulnerable to such actions.


Interactions between pharmaceutical representatives and doctors in training: In considering advertising practices within the sphere of the market for healthcare and medical-pharmaceutical care, the problems resulting from self-regulation take on even more significant dimensions.

Evidence presented in various studies conducted in Brazil and abroad provide the empirical basis for the arguments developed here. However, this necessary interdiction cannot be the only action to be taken. They concluded that the randomized clinical trials analyzed significantly favored the experimental interventions when there was a declared conflict of interest regarding funding. They concluded that restricting the access of pharmaceutical representatives to interns and residents seemed to affect 177 physicians’ future attitudes and 6347.

However, this alternative does not appear to bring benefits for patients, ve that the treatment on offer is not necessarily better than others for which no free samples are available.

Researchers funded by the pharmaceutical industry may introduce interpretation bias into their analyses that possibly will not be noticed by specialist reviewers, and evidence of this is already available.

Zipkin and Steinman carried out a thematic review through Medline, among articles published in the English language between andregarding medical training and the pharmaceutical industry.

However, it could be argued that accepting free samples or not has no effective significance with regard ce changing prescriptions; or 647 distribution of gifts is irrelevant; or that the harassment by marketing agents has the single purpose of publicizing studies that have been conducted and updating physicians regarding innovations, given that it is the industry that invests in technology; or that what is more relevant is the quantity of systematized evidence that the advertising provides, thereby supplying a scientific basis for changing prescriptions.

Services on Demand Article. Possible consequences on the training process and the technical quality of trained professionals Harassment of medical professionals by pharmaceutical companies may also compromise the professional training of medical students. Society in general, and healthcare professionals especially, need to be mobilized to demand transparency from their researchers and scientific writers, in their relationships with the pharmaceutical industry and other sources of funding.